Supermum is taking a break this week but will be back with her regular Weekly Chart View next weekend....

A Brief Look At The Week Ahead

After a few light results weeks and the long Easter weekend, the City is set to resume normal service this week, fronted by a couple of the real heavyweights; Tesco and BP. Tesco is expected to unveil another year of unswerving growth when it publishes full-year results on Tuesday with profits of over 2.2bn anticipated. Investors will be hoping for news of more cashback plans tied up with re-shaping the company's property portfolio. Also on Tuesday, BP takes the floor. Just a week after the oil price broke yet another record, pushing above $74 per barrel, Williams de Broexpects the company to post $5.24bn in net income for the first three months of the year. More important than those numbers, however, will be the company's view about production for the rest of the year and to what degree its massive share buyback program, funded by the soaring oil price, is likely to continue. Imperial Tobacco should light up Wednesday with Williams de Broexpecting the group to report 543m in pre-tax profit, a 10% jump over the same period last year. As much as analysts would like its CEO to give his view on a JP Morgan research note that suggested IMT should buy the Franco-Spanish rival Altadis, he is unlikely to say a word. Thursday is set to be a "medical day" as AstraZeneca, GlaxoSmithKline and Shire line up to publish interim results, along with prosthetics maker, Smith & Nephew. GlaxoSmithKline is arguably the best positioned among its peers in terms of new drugs in development. Williams de Broexpects 1.8bn in profits before tax. Goldman predicts $401m, 20% ahead of the year before, from Shire Pharma, on the back of surging sales for its hyperactivity treatment, Aderrall XR. Investors, however, continue to worry about the attempts by Barr Pharmaceuticals to make a cheap generic version of the drug. The US Food and Drug Administration said last week that it needs more time to test copycat versions, which could lead Barr to the negotiating table. Solid numbers are expected from Smith & Nephew, rather than anything very exciting. Other companies under scrutiny this week will include Peter Hambro Mining on Monday; Whitbread on Tuesday; Amvescap on Wednesday, with Reckitt Benckiser and Fortune Oil on Thursday. A busy week in prospect, whatever sector interests you. Should be fun! Good hunting! Greystone (Greystone is Alan English, City Editor at MoneyAM.)

OMH (Osmetech) Tipped as a BUY in todays Sunday Telegraph
Sunday Telegraph (UK) - Apr. 23, 2006

KEEP an eye on Osmetech, the healthcare diagnostics group (24p).

Under the stewardship of James White, the company has developed into a business with sales, mainly thanks to a handful of acquisitions.

In results published last month, Osmetech revealed that sales for the eight months to December 31 were up by 78 per cent on the corresponding period.

Its investment in its critical care business is also paying off, with sales up by 64 per cent to $14.8m ( pounds 8.3m).

Since then it has announced the launch of its eSensor cystic fibrosis carrier detection (CFCD) test and its eSensor 4800 DNA detection instrument.

The eSensor system can be used to perform molecular tests that require the simultaneous analysis of multiple genetic information. Product shipments are expected to begin on schedule during the first half of this year, the company said.

We believe the shares look like good value. Buy.

This is my selection for the "UPS" this week CHP

Share	Volume	Chart	News	Various
CHP price 16.125p	Higher volume buying than usual last Friday	Last week end of pendant on the chart has change the direction on the share price, now the MACD is crossing on the way up an becomes more positive	Still waiting for an update of flowing rates on Puerto Lopez, Colombia are ahead of previous expectations, has recently raised funds which should see it through its current near term exploration budget	Has three exploration blocks in Colombia and 3 in Paraguay with new updates about some of the blocks around the end of this month and next

Chart for CHP

Good morning traders!

In Asia today, the Hang Seng ended the morning down 129.65 points at 16,782.50, while the Nikkei was recently 401.22 points lower at 17,002.74.

New York's main oil contract, light sweet crude for June delivery, was at $74.85 a barrel compared with its record close of $75.17 in the US last Friday.

Happy trading!

G.

Morning all.

Good morning all

PET 46 -48p +3p
now is on the move up with the L2 and improve 1 v 1

only the MM at offer not blue, the rest have move the prices
after steying at around 42 - 44p last Friday gave signs of live

UPS (Added by Master RSI on Mon 24 Apr 08:50 am)
MTA - Mid 7.875p

Reason Large buying this morning after a BREAKOUT on the chart, change of name adquisitions of oil block lately commenced drilling its first exploration well, Blue Topaz-9

Midday Market Summary

             LUNCH TIME FUN

      

LOL!

SEO 13 -13.25p

the shares are on the turn since late last week

Indicators MACD has been crossing on the way up
RSI and slow Stochastic rising from oversold

Any thoughts on Phytopharma PYM, feel there could be a big move north. Would appreciat your comments... REsults out on the 9th may, could be some specualative buying going on

End-of-day Market Summary

Tonker - This sort of stuff is certainly going to help - today's news :-

Phytopharm added 1.75p at 49.25p after launching Phytopica, a treatment for allergic skin conditions in dogs.

           JOKE OF THE DAY

The Suppository
A man with a bad stomach complaint goes to his doctor
and asks him what he can do.

The doctor replies that the illness is quite serious but can be
cured by inserting a suppository up his anal passage.

The man agrees, and so the doctor warns him of the pain,
tells him to bend over and shoves the thing way up his behind.

The doctor then hands him a second dose and tells him
to do the same thing in six hours.

So, the man goes home and later that evening tries to get the
second suppository inserted, but he finds that he cannot reach
himself properly to obtain the required depth.

He calls his wife over and tells her what to do.
The wife nods, puts one hand on his shoulder to steady him
and with the other shoves the medicine home.

Suddenly the man screams, "DAMN!"

"What's the matter?" asks the wife. "Did I hurt you?"

"No," replies the man,
"but I just realized that when the doctor did that,
he had BOTH hands on my shoulders!